A phase II trial of Capecitabine (X) and Irinotecan (I) in a biweekly schedule in patients with untreated advanced colorectal cancer (ACRC)

P. Garcia-Alfonso, G. Perez MAnga,M. C. Gonzalez,P. Lopez,E. Gonzalez, J. Belon,M. Molina, V. Pachon, L. Iglesias, I. Siso

EJC SUPPLEMENTS（2005）

Cited 0|Views2

No score

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined